Mrs Hina A Patel, RPH | |
2148 Morris Ave, Union, NJ 07083-6006 | |
(908) 687-4994 | |
Not Available |
Full Name | Mrs Hina A Patel |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 2148 Morris Ave, Union, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093098337 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 28RI02418600 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Hina A Patel, RPH 2148 Morris Ave, Union, NJ 07083-6006 Ph: (908) 687-4994 | Mrs Hina A Patel, RPH 2148 Morris Ave, Union, NJ 07083-6006 Ph: (908) 687-4994 |
News Archive
Rutgers researchers have discovered a new mechanism that may contribute to Alzheimer's disease and traumatic brain injury. They now hope to launch a clinical trial to test the treatment in humans.
A new study has shown that even secondhand smoke can raise the risk of metabolic syndrome, a condition marked by obesity, high blood pressure, unhealthy cholesterol levels and pre-diabetes.
Health-overhaul legislation signed into law this week will affect not only America's health care industry, but the broader economy, too, The Christian Science Monitor reports. The overhaul could help create jobs. "But the legislation also means tax hikes, mainly on the highest-income Americans. And provisions designed to curb healthcare costs probably aren't strong enough to put a big dent in medical inflation - or federal budget deficits" (Trumbull, 3/24).
But the survey underway in Prince George's County is intended to address a complex problem. Officials expect the data to give them a detailed look at the state of health and health care in the county, where conditions such as diabetes and heart disease are much more common than in the rest of the region and most of the state.
OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.
› Verified 8 days ago
Dr. Theresa Ogechi Nnoli, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2148 Morris Ave, Union, NJ 07083 Phone: 908-687-4994 | |
Neil Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 327 Chestnut St, Union, NJ 07083 Phone: 908-686-1212 | |
Harmeet Chahil, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2690 Us Highway 22 E, Union, NJ 07083 Phone: 908-688-1244 | |
Nidhi P Borad, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 327 Chestnut St, Union, NJ 07083 Phone: 908-686-1212 | |
Dr. Thy M Tran, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2690 Route 22 E, Union, NJ 07083 Phone: 908-688-1244 Fax: 908-688-1244 | |
Dr. Monika Zadlo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1055 Hudson St, Union, NJ 07083 Phone: 908-810-1782 |